RESOURCES

Use Cases

How Pharma & Agencies put the signals to work

Blogs

Intelligence at the intersection of data science and real-life health

The Talking Room

Demystifying AI, LLMs and machine learning

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About TMLabs

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Methodologies and validated outcomes

Latest paper

Understanding Unstructured Consumer Conversations in the GLP-1 Space

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence change

SEE IT IN ACTION

Challenge us!

See which messages resonate with different audiences, understand why, and where relevant, examine their association with intent-to-prescribe.

ABOUT US

About us

Our story, our mission and the people behind it

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Challenge us!

A team built around one problem: making real-life conversation usable at scale.

Article

Mastering Brand Impact: Unleashing the Power of AI-Driven Data for Pharma Clients

Jan 22, 2024

← All articles

In this article

Share

In the fast-evolving landscape of Healthcare Marketing, the dominance of Artificial Intelligence (AI) is revolutionizing the game. With Advanced Data Science and AI leading the charge, we are not just talking about trends; we are entering an era where being data-first is an absolute strategic imperative. The stats speak for themselves – 61.4% of savvy marketers have already integrated AI into their arsenal (Artificial Intelligence Benchmark Report: 2023 by Influencer Marketing Hub). For agency strategists, embracing this transformative wave isn’t just an option; it’s a non-negotiable step toward staying ahead in the healthcare marketing evolution. 

The burning question at the core of our strategic discussions is this: How does data become the driving force behind brand equity in our marketing strategies? 

According to the American Marketing Association (2022), brand equity is the intangible value that defines how well a brand is recognized, perceived, and trusted in the market. It’s not just a buzzword; it’s a game-changer in the healthcare marketing arena. 

Let’s cut to the chase. This blog is access to a playbook for leveraging Advanced Data Science and AI-powered data to architect brand equity for your Pharma clients. No fluff, just actionable insights and strategies that will not only resonate with your audience but will also reshape your client’s brand influence in the healthcare landscape. 

Precision Messaging Unleashed:
 

Beyond traditional targeting; now we’re talking about precision messaging that hits the bullseye spot. AI empowers you to proactively A/B test messaging before the big launch, providing invaluable insights for strategic refinements. No more relying on limited focus groups and biased samples – AI opens the door to a world of conversational data where you can pinpoint what resonates among patients, HCPs, or Influencers. 

Unlock the power of AI to access a treasure trove of conversational analysis.

Use AI as your secret weapon for implementing approaches that cut through the noise to foster engagement.  As agency strategists, the mission is clear – strengthen brand equity by not just listening but proactively responding to the unique needs and preferences of our audience. 

In conclusion, this is not a trend; it’s a strategic shift. For agency strategists who seize the power of Advanced Data Science and AI, navigating the dynamic healthcare marketing landscape is not a challenge; it is an opportunity to redefine brand equity and leave a mark on the evolving healthcare scene. Master the AI game, strategists – book a call to see how the AI playbook enhances your strategies today. 

  

About Talking Medicines: 

Talking Medicines is revolutionizing healthcare marketing by unlocking strategic intelligence within Conversational Data. Talking Medicines empowers Customers to gain the strategic advantage in analysis, measurement and enhanced brand equity through structuring Conversational Data. Leveraging the power of data science, our PatientMetRx® platform combines Advanced Artificial Intelligence, Natural Language Processing (NLP), Large Language Models (LLMs), and human expertise to provide a comprehensive source of truth.

Stay ahead of message impact

Know which messages change behaviour, before the prescriptions are written.

Transforming millions of real-life conversations into curated intelligence.

Evidence-led insights powered by DrugVoice and the Message Resonance™ Score. Roughly two a fortnight, straight from the teams building the models.

Subscribe on LinkedInFollow Talking Medicines

Keep reading

More from the same topic.

Loading...